(Updated - June 7, 2021 4:47 PM EDT)

Baird analyst Brian Skorney upgraded Biogen (NASDAQ: BIIB) from Underperform to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE